|
TCRX Tscan Therapeutics Inc 1783328 |
| Balance Sheet |
|
Current Assets
|
$104,403,000.00 |
|
Assets
|
$171,452,000.00 |
|
Current Liabilities
|
$30,964,000.00 |
|
Liabilities
|
$102,433,000.00 |
|
Equity
|
$69,019,000.00 |
|
Shares Out
|
61074000.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-51,814,000.00 |
|
Investing Cash Flow
|
$-535,000.00 |
| Market Analysis |
Market Cap
|
$47,637,720.00 |
|
Price
|
$0.78 |
|
PB
|
6.33 |
|
EPS
|
-0.23 |
|
PS
|
11.33 |
|
FCF
|
$-52,377,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:54 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:44 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.28 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TCRX documents filed with the SEC.
TCRX Filings
Clear
